Data from BriaCell and the US National Cancer Institute (NCI) support the cancer cell killing potential of BriaCell’s Bria-OTS+ platformBria-OTS+, a novel personalized, off-the-shelf, semi-allogeneic cellular immunotherapy may address urgent unmet medical needs for patients with cancer This study was conducted in collaboration with the NCI PHILADELPHIA and VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “C ...

RYE, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of Bancroft Fund Ltd. (NYSE American: BCV) (the “Fund”) increased the quarterly distribution to $0.35 per share. The increased quarterly distributions will commence with the distribution payable in December 2025. This is a 10% increase from $0.32 per share, bringing the annualized distribution rate to $1.40 from $1.28 per share. The increase underscores the strength of the Fund’s NAV total return of 20% year to date. Investors should careful ...

Core Insights - Draganfly Inc. is strategically positioned to support Canada's $2 billion military aid package to Ukraine, with over $220 million allocated for drone and electronic warfare capabilities [1][2] - The company's extensive experience in drone technology and its active involvement in Ukraine since 2022 enhance its ability to contribute to defense initiatives [2][3] - Draganfly's capabilities include advanced UAV solutions, counter-drone systems, and support for ISR, demining, and logistics [3][4] Strategic Alignment - Canada's military aid underscores its commitment to defending democracy and resisting authoritarianism, with a significant portion of funding directed towards advanced drone technologies [2] - The partnership between Canadian and Ukrainian defense companies is emphasized, with Draganfly's engineering expertise being a key asset [2][3] Military-Grade Capabilities - Draganfly has a proven track record in defense and humanitarian response, showcasing its advanced drone systems and counter-drone technologies [3] - The company is expanding its capabilities through domestic and international defense contracts, R&D investments, and partnerships with NATO-aligned nations [3] Company Overview - Draganfly Inc. is a pioneer in drone solutions, AI-driven software, and robotics, with over 25 years of innovation in the industry [4] - The company focuses on delivering reliable technology for various applications, including public safety, agriculture, and industrial inspections [4]

Core Insights - Gilat Satellite Networks Ltd. has signed a $25 million agreement with Pronatel to modernize the Regional Broadband network in the Cusco region of Peru, enhancing connectivity for public institutions [1][2][3] - The upgraded network will provide high-speed internet of 200 Mbps to approximately 208 public institutions and 69 public free WiFi hotspots, improving access to essential services such as education and healthcare [2][3] - This initiative reflects Gilat's ongoing commitment to digital inclusion and its partnership with the Peruvian State, aiming to strengthen critical public services in remote areas [3][4] Company Overview - Gilat Satellite Networks Ltd. is a leading global provider of satellite-based broadband communications, with over 35 years of experience in delivering technology solutions for various applications [4][5] - The company offers a comprehensive portfolio that includes cloud-based platforms, high-performance satellite terminals, and integrated ground systems for both commercial and defense markets [5][6] - Gilat's products support multiple applications, including government, defense, broadband access, and critical infrastructure, while adhering to stringent service level requirements [6]

Company Overview - Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company focused on developing transformative therapies for autoimmune diseases [2] - The company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody targeting CD19 and FcγRIIb to inhibit the activity of B cells involved in autoimmune diseases without depleting them [2] - Zenas aims to leverage its experienced leadership and disciplined product acquisition strategy to identify and develop candidates that provide superior clinical benefits for patients [2] Upcoming Events - Zenas will present at the Citi's 2025 Biopharma Back to School Conference on September 2, 2025, at 1:00 p.m. ET [3] - The company will also participate in the Cantor Global Healthcare Conference 2025 on September 3, 2025, at 8:35 a.m. ET [3] - Additionally, Zenas is scheduled to present at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, 2025, at 7:45 a.m. ET [3]

Core Insights - Kraig Biocraft Laboratories, Inc. has established two new rearing centers in a leading silk-producing region in Asia, replacing its original Prodigy Textiles pilot facility as the main production center [1][4]. Production Achievements - Since the opening of the first rearing center in early 2024, the company has produced more recombinant spider silk than in all previous years combined, indicating a significant increase in production capacity [2]. - The new rearing centers combine advanced biotechnology with the region's sericulture expertise, favorable climate, and established infrastructure, optimizing the production environment [2]. Operational Developments - The company has begun transferring equipment from the original pilot facility to the new commercial production centers, with completion expected by the end of August [3]. - The new facilities will be operated by the company's wholly owned subsidiary, Prodigy Silk, while the Prodigy Textile brand will continue as a DBA of Kraig Labs [3]. Strategic Milestones - The establishment of the new rearing centers represents a major milestone for Kraig Labs, aligning with its expansion objectives for 2025 and enhancing its ability to commercialize spider silk [4]. - This development is the result of nearly a decade of planning, positioning the company to leverage the region's advantages and its scientific advancements [4].

Core Insights - EDAP TMS SA has announced a letter of intent for a EUR 36 million credit facility with the European Investment Bank (EIB) to support the growth of Focal One Robotic HIFU in the treatment of early-stage prostate cancer [1][2] - The financing will enhance the company's balance sheet and provide low-interest funding accessible in tranches as needed [2] - The credit facility is expected to close by the end of Calendar Year 2025, pending final legal documentation [1] Company Overview - EDAP TMS SA is a leader in robotic energy-based therapies, developing and distributing minimally invasive medical devices using ultrasound technology [3] - The company introduced Focal One as a leading prostate focal therapy, with potential applications beyond prostate cancer [3]

SHANGHAI, Aug. 26, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced unaudited financial results for the quarter ended June 30, 2025. “The strong momentum we built in 2024 and early 2025 continued in the second quarter,” said Ziyu Shen, ECARX Chairman and CEO. “Revenue was US$155.6 million, reflecting the impact of typical seasonal headwinds and the timing of certain contracts, while the disciplined execution of our lean o ...

MELBOURNE, Australia and INDIANAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 4:50 p.m. ET on Monday, September 8, 2025 (6:50 a.m. AEST, Sep 9) and at the H.C. Wainwright 27th Annual Global Investment Conference at 12:00 p.m. ET on Tuesday, September 9, 2025 (2:00 a.m. AEST, Sep 10). Dr. Christian Behrenbruch, Managing Director and Group CEO, will participate in fireside c ...

Core Insights - Baker Hughes has secured a long-term service agreement with bp for the Tangguh LNG plant in Papua Barat, Indonesia, lasting 90 months, which includes spare parts, repair services, and engineering support for critical turbomachinery [1][5] - This agreement builds on a partnership that dates back to 2009, highlighting Baker Hughes' ongoing role in supporting bp's energy projects [2] - The Tangguh LNG facility is crucial for Indonesia's energy strategy and the Asia-Pacific region's energy supply, with Baker Hughes' support ensuring the reliability of essential turbomachinery [3] Company and Industry Summary - The agreement emphasizes Baker Hughes' commitment to advancing energy development in Indonesia and its strategic focus on LNG equipment asset management services [4][5] - Baker Hughes is collaborating with local partner PT Imeco Inter Sarana to meet local content requirements, showcasing its dedication to local engagement [4] - The company aims to expand its service capabilities in the Asia-Pacific region to address growing energy demands and transition needs [5]